NCT06248983

Brief Summary

Through contact with peers in daycare and (primary)school young children play a large role in spreading respiratory pathogens. In this study the investigators will investigate this transmission, the subsequent colonization and infection dynamics, and their association with clinical symptoms and local immune response through dense minimally-invasive sampling. This study will allow us a unique insight into the transmission-, infection-, and colonization-potential of the respiratory pathogens.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
56

participants targeted

Target at P25-P50 for all trials

Timeline
Completed

Started Feb 2024

Shorter than P25 for all trials

Geographic Reach
1 country

2 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

January 31, 2024

Completed
8 days until next milestone

First Posted

Study publicly available on registry

February 8, 2024

Completed
18 days until next milestone

Study Start

First participant enrolled

February 26, 2024

Completed
2 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 26, 2024

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

April 26, 2024

Completed
Last Updated

July 11, 2024

Status Verified

July 1, 2024

Enrollment Period

2 months

First QC Date

January 31, 2024

Last Update Submit

July 10, 2024

Conditions

Outcome Measures

Primary Outcomes (1)

  • Classroom transmission- and colonization-rate of Streptococcus pneumoniae in young children.

    To answer the primary objective the investigators will record pneumococcus carriage over time at a serotype level using qPCR. This will lead to a categorical variable with the following levels for each included serotype, per participant: never infected (no Spn detected during the sampling period), already colonized (Spn detected at the start of the sampling period), new colonization (Spn not detected at the start of the sampling period, but detected in the course of the sampling period) or re-colonization (same Spn serotype detected during sampling period with at least 3 samples in between not detecting Spn). A transmission event will be defined as a Spn serotype that is observed in at least one child in the class and at a later timepoint also observed in one or more other children, as long as this is within 1 week of it being present in first child.

    8 weeks

Secondary Outcomes (4)

  • Transmission and colonization rates of other URT pathogens in a classroom setting.

    8 weeks

  • Nasal immune response in response to exposure, infection or colonization by URT microbes.

    8 weeks

  • The relationship between clinical symptoms of RTI's, host immune responses, microbiome and URT pathogens.

    8 weeks

  • pollen and bacterial presence (airobiome) in classroom environment via electrostatic dust fall collector and pollensniffer to differentiate between RTI and hay fever.

    8 weeks

Study Arms (1)

Participants

Observational study, therefore no intervention that is administered.

Eligibility Criteria

Age4 Years - 99 Years
Sexall
Healthy VolunteersYes
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Children attending primary school, age 4-7 (year 1-2 of primary education) and their teachers. The investigators aim to include minimal 80% of children in a given class. In total the investigators aim to include three classes within one season.

You may qualify if:

  • Within age-limit
  • attending primary school

You may not qualify if:

  • Insufficient proficiency of their parents in Dutch or English language
  • Teachers:
  • Adult teacher of participating primary school class
  • Insufficient proficiency in Dutch or English language

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

Spaarne Gasthuis

Hoofddorp, North Holland, 2134TM, Netherlands

Location

Leiden University Medical Centre

Leiden, Zuid-Hollend, 2333 ZA, Netherlands

Location

Biospecimen

Retention: SAMPLES WITHOUT DNA

Nasal epithelial lining fluid will be sampled using a nasosorption device

MeSH Terms

Conditions

Respiratory Tract InfectionsCommunicable Diseases

Condition Hierarchy (Ancestors)

InfectionsRespiratory Tract DiseasesDisease AttributesPathologic ProcessesPathological Conditions, Signs and Symptoms

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Associate professor

Study Record Dates

First Submitted

January 31, 2024

First Posted

February 8, 2024

Study Start

February 26, 2024

Primary Completion

April 26, 2024

Study Completion

April 26, 2024

Last Updated

July 11, 2024

Record last verified: 2024-07

Data Sharing

IPD Sharing
Will not share

Locations